Methodology for computing the burden of disease of adverse events following immunization

15Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: Composite disease burden measures such as disability‐adjusted life‐years (DALY) have been widely used to quantify the population‐level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immu-nization. Our objective was to assess the feasibility of adapting the DALY approach for estimating adverse event burden. Methods: We developed a practical methodological framework, explicitly describing all steps involved: acquisition of relative or absolute risks and background event incidence rates, selection of disability weights and durations, and computation of the years lived with disability (YLD) mea-sure, with appropriate estimation of uncertainty. We present a worked example, in which YLD is computed for 3 recognized adverse reactions following 3 childhood vaccination types, based on background incidence rates and relative/absolute risks retrieved from the literature. Results: YLD provided extra insight into the health impact of an adverse event over presenta-tion of incidence rates only, as severity and duration are additionally incorporated. As well as pro-viding guidance for the deployment of DALY methodology in the context of adverse events associated with vaccination, we also identified where data limitations potentially occur. Conclusions: Burden of disease methodology can be applied to estimate the health burden of adverse events following vaccination in a systematic way. As with all burden of disease studies, interpretation of the estimates must consider the quality and accuracy of the data sources con-tributing to the DALY computation.

Cite

CITATION STYLE

APA

McDonald, S. A., Nijsten, D., Bollaerts, K., Bauwens, J., Praet, N., van der Sande, M., … Hahné, S. (2018). Methodology for computing the burden of disease of adverse events following immunization. Pharmacoepidemiology and Drug Safety, 27(7), 724–730. https://doi.org/10.1002/pds.4419

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free